Telix Pharmaceuticals (TLPPF) Inventory Average (2024 - 2026)

Telix Pharmaceuticals (TLPPF) has reported Inventory Average for 3 consecutive years, with $38.1 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Inventory Average changed N/A year-over-year to $38.1 million in Q2 2026; TTM through Jun 2026 was $38.1 million, a N/A change from a year earlier, with the FY2025 full-year figure at $30.4 million, up 66.95% from the prior year.
• Inventory Average was $38.1 million for Q2 2026 at Telix Pharmaceuticals, up from $31.0 million in the prior quarter.
• Over five years, Inventory Average peaked at $38.1 million in Q2 2026 and troughed at $18.1 million in Q4 2024.
• A 3-year average of $29.1 million and a median of $31.0 million in 2025 frame the typical range for Inventory Average.
• The widest YoY moves for Inventory Average: up 71.28% in 2025, down 71.28% in 2025.
• Over 3 years, Inventory Average stood at $18.1 million in 2024, then surged by 71.28% to $31.0 million in 2025, then increased by 22.71% to $38.1 million in 2026.
• The last three Inventory Average figures came in at $38.1 million (Q2 2026), $31.0 million (Q4 2025), and $18.1 million (Q4 2024), per Business Quant data.